At a glance
ClinicalIndex Comparison RecordN/ACompleted· 77 enrolled
Drug / intervention
Control Lenses (comfilcon A with current process) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Evaluation of Comfilcon A Contact Lenses
In Brief
A clinical study evaluating Control Lenses (comfilcon A with current process) and Test Lenses (comfilcon A with novel process) for Myopia. Completed, enrolled 77 participants across 5 sites.
Detailed Summary
The purpose of this study was to confirm the clinical performance of a novel manufacturing process for comfilcon A contact lenses in habitual wearers over a one-month period of lens wear.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202420252026
First PostedNov 2023
Enrollment StartNov 2023
Primary CompletionMar 2024
TodayJul 2026
First PostedNov 7, 2023
Enrollment StartNov 14, 2023
Primary CompletionMar 1, 2024
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 2.7 years ago
Interventions
Control Lenses (comfilcon A with current process)device
Daily wear lenses for 30±2 days
Test Lenses (comfilcon A with novel process)device
Daily wear lenses for 30±2 days